Financial Data and Key Metrics Changes - Net investment income for Q4 2025 was $0.36 per share, and $1.45 for the full year, indicating a yield to book value of 2.7% for Q4 and 11% for the year [4][18] - Gross investment income totaled $14.2 million for Q4, down from $15.1 million in Q3, primarily due to one-time fees from unscheduled repayments recognized in Q3 [17] - Net investment income for Q4 was $8.3 million, compared to $9.5 million in Q3, reflecting a decrease due to one-time fees [18] - Net assets totaled $303.4 million at quarter end, with a net asset value per share of $13.30, slightly up from $13.27 in Q3 [18] Business Line Data and Key Metrics Changes - The company funded $31.7 million across 7 new investments in Q4, including 4 new borrowers, with 100% of these being senior secured loans [5][20] - The average credit investment size was approximately 2.4% of the debt portfolio at fair value, with 25% of the portfolio invested in non-cannabis companies [16] Market Data and Key Metrics Changes - The broader BDC market faced negative sentiment, with many BDCs trading below net asset value by the end of 2025, leading to concerns about potential dividend cuts and losses in existing loan books [5] - The weighted average yield on debt investments was 15.8%, compared to 10.8% for the average public BDC [9] Company Strategy and Development Direction - The company focuses on direct loans to privately held companies in niche markets, particularly the cannabis sector and lower middle market, which are often overlooked by capital providers [4][6] - The strategy emphasizes downside protection and aims to deliver attractive returns through disciplined credit and collateral focus [8][13] - Recent M&A activity in the cannabis market has increased the company's pipeline for 2026, with a total of approximately $732 million in potential debt transactions [11][22] Management's Comments on Operating Environment and Future Outlook - Management noted that the recent shift in cannabis policy at the federal level could significantly increase cash flow for borrowers, leading to higher equity valuations and increased M&A activity [12] - The company remains cautious about the regulatory environment but believes it is well-positioned to benefit from developments in the cannabis sector [13] - Management highlighted that the current market anxiety presents opportunities for disciplined lenders, as they can capitalize on the strengths of their portfolio and liquidity [25] Other Important Information - The company has a low debt-to-equity ratio of 0.08x, significantly below the BDC average of 1.2x, and has no non-accruals compared to an industry average of 3.3% [11] - The company announced a $0.34 dividend, marking the sixth consecutive quarter at that rate, with total dividends for the year amounting to $1.36 per share [11] Q&A Session Summary Question: Clarification on the $732 million pipeline - The pipeline figure refers to the entire Chicago Atlantic Group platform, showing an increase from approximately $600 million reported last quarter [31] Question: Impact of rescheduling discussions on borrower activity - Management noted increased eagerness among larger players for consolidation and operators considering exits, which is positive for financing opportunities [33] Question: Activity in specific states regarding cannabis - There is increased activity in states like Virginia and ongoing consolidation in mature markets such as Ohio and Colorado [35] Question: Potential for increasing the credit facility - There is room to increase the revolver in 2026, along with other financing options available to BDCs [36] Question: Insights on repayments in Q4 and Q1 - The higher-than-expected repayments were idiosyncratic across several borrowers, reflecting broader transaction activity in the market [44]